Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01329952
What this trial is testing

Reinfection and Long Term Outcomes in Intravenous Drug Users (IVDUs) After Hepatitis C Treatment

Who this might be right for
Hepatitis C
Pennine Acute Hospitals NHS Trust 90
Testing effectiveness (Phase 2)Study completedNCT00255177
What this trial is testing

Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients

Who this might be right for
Hepatitis C Virus Infection
VGX Pharmaceuticals, LLC 44
Not applicableStudy completedNCT04139941
What this trial is testing

Evaluation Study of HCV RDTs in Fresh Samples

Who this might be right for
Hepatitis C Virus Infection
Foundation for Innovative New Diagnostics, Switzerland 1,540
Testing effectiveness (Phase 2)Study completedNCT01121731
What this trial is testing

A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus InfectionGenotype 1Treatment-Experienced Patients+1 more
Digna Biotech S.L. 70
Not applicableStudy completedNCT02439567
What this trial is testing

Transient Elastography to Assess Liver Fibrosis and Portal Hypertension in HCV Cirrhotic Patients Treated With New Antiviral Drugs (SPLEEN-C)

Who this might be right for
Chronic Hepatitis CCirrhosisPortal Hypertension
Hospital Universitari Vall d'Hebron Research Institute 41
Large-scale testing (Phase 3)Study completedNCT02103439
What this trial is testing

An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients

Who this might be right for
HepatitisHepatitis CHepatitis C/ Human Immunodeficiency Virus Coinfection
Biocad 140
Post-approval studies (Phase 4)Study completedNCT03961828
What this trial is testing

Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus

Who this might be right for
Beta-ThalassemiaHepatitis C
Tanta University 50
Not applicableWithdrawnNCT01831037
What this trial is testing

The Regression of Liver Fibrosis and Risk for Hepatocellular Carcinoma (ROLFH) Study

Who this might be right for
Chronic Hepatitis CChronic Hepatitis B
University of Arkansas
Early research (Phase 1)UnknownNCT02126137
What this trial is testing

Pilot Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C
Pontificia Universidad Catolica de Chile 20
Large-scale testing (Phase 3)WithdrawnNCT02890719
What this trial is testing

Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients.

Who this might be right for
Liver TransplantationHepatitis C
Fundacion Clinic per a la Recerca Biomédica
Large-scale testing (Phase 3)Study completedNCT00657397
What this trial is testing

Initialization of Methadone in Primary Care, Randomized Intervention Research for Preventing HCV Transmission Practices

Who this might be right for
Hepatitis CSubstance DependenceMethadone
French National Agency for Research on AIDS and Viral Hepatitis 197
Testing effectiveness (Phase 2)Study completedNCT00790673
What this trial is testing

CF102 in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
Can-Fite BioPharma 32
Post-approval studies (Phase 4)WithdrawnNCT00167557
What this trial is testing

Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment

Who this might be right for
Hepatitis C
The University of Texas Health Science Center, Houston
Large-scale testing (Phase 3)Study completedNCT01667731
What this trial is testing

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Who this might be right for
Hepatitis CHuman Immunodeficiency Virus
Gilead Sciences 224
Not applicableEnded earlyNCT01040039
What this trial is testing

Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV

Who this might be right for
HIV InfectionsHepatitis C Virus
Rockefeller University 20
Testing effectiveness (Phase 2)UnknownNCT00281502
What this trial is testing

The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyHepatitis CLiver Cirrhosis
Weill Medical College of Cornell University 50
Large-scale testing (Phase 3)Study completedNCT00381953
What this trial is testing

High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

Who this might be right for
Hepatitis C
Foundation for Liver Research 33
Testing effectiveness (Phase 2)Study completedNCT01072695
What this trial is testing

Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
HCV Infection
Gilead Sciences 46
Not applicableStudy completedNCT00001712
What this trial is testing

Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan

Who this might be right for
Hepatitis BHepatitis CHIV Infection
National Institutes of Health Clinical Center (CC) 3,400
Early research (Phase 1)Study completedNCT01497327
What this trial is testing

Open-Label Hepatic Impairment Study

Who this might be right for
Hepatitis C
Gilead Sciences 24
Next Page